Navigation Links
Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
Date:5/16/2008

Xceed's Dr. David Englert and Dr. Zhe Zhang of Children's Hospital of Philadelphia will present data at a luncheon workshop on Wednesday, May

21st

WELLESLEY, Mass., May 16 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that the company will feature its Ziplex Automated Gene-Expression System at Biomarker World Congress, booth 16. Currently available for research use only in the US and Canada, the Ziplex System is the first integrated system for automated gene-expression analysis. It comprises an automated hybridization workstation, TipChip consumable arrays, reagents, and analysis/reporting software. Biomarker World Congress takes place May 19-21, 2008, at the Loews Philadelphia Hotel in Pennsylvania.

"Translational research (the movement of existing gene-expression biomarkers from basic science into routine clinical use for patient diagnostics) -- and the ultimate goal of personalized medicine -- has been hampered because the available technology to process microarrays is complex, expensive, and time-consuming," said Xceed's President and CEO, David Deems. "Results from traditional technology are also prone to unacceptable levels of variability to meet the rigorous performance and quality-control needs of the clinical-diagnostic laboratory. Xceed designed the Ziplex System with turnkey functionality and significant advances in automation, array format, fluidics, parallel sample processing, and analytics to minimize complexity, user interaction, and variability between users and sites. Our goal: to make routine molecular diagnostics easy, reproducible, and affordable to serve the needs of both clinical research and clinical-diagnostic settings -- which demand that results remain consistent even when samples are run by different people, at different times, or in different sites."

Luncheon Workshop

Xceed is hosting a luncheon workshop from 12 to 1:30 pm, on Wednesday, May 21, 2008, in the Howe Room of the Loews Philadelphia Hotel.

Ziplex System for Focused Content, Multiplexed Gene-Expression Analysis -- Introduction and Study Results

David Englert, Ph.D., VP, Technology Development, Xceed Molecular, Toronto.

Identification of a Diagnostic Classifier of Cornelia de Lange Syndrome, an Often Misdiagnosed and Little-Known Genetic Syndrome, Through a Stepwise and Multi-Platform Procedure

Zhe Zhang, Ph.D., Bioinformatics Core, Center for Biomedical Informatics, Children's Hospital of Philadelphia

Dr. Zhe Zhang is also presenting a poster on the subject, which will be available for viewing throughout the conference (Poster #11).

About Xceed Molecular

Xceed's vision is to advance molecular diagnostics by successfully translating novel multiplex tests into routine clinical practice and to create robust diagnostic solutions to improve disease outcomes. Our products comprise the Ziplex(R) System for automated gene-expression analysis (available in the US and Canada for research use only), gene expression services, and pre-configured arrays. Xceed is also developing multiplexed genomic tests for the Ziplex platform, both internally and with strategic partners. Xceed's R&D and manufacturing are headquartered in Toronto, Ontario, with executive offices in Wellesley, Massachusetts. For more information, visit http://www.XceedMolecular.com.


'/>"/>
SOURCE Xceed Molecular
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million
2. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
3. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
4. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
5. Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community
6. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
7. CrossFire Beilstein Database Exceeds Ten Million Compounds
8. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
9. Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
10. SimBioSys Utilizes Revolutionary Hardware Technology to Open New Frontiers in Molecular Modeling
11. DermTech Study on Melanoma Molecular Diagnostic to Be Presented at AACR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... , ... Executive search firm Slone Partners proudly supports the ... advancement of the clinical trials segment. Hosted in Miami, this conference brings together ... management. , As executive talent specialists in the industries central to clinical ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated ... year and is planned for further growth in 2017. Extractable & Leachable evaluations ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... today announced that it has submitted a 510(k) to the FDA, requesting clearance ... MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The submission marks a ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev ... examine vital clinical research issues such as trial performance metrics, patient enrollment diversity, ...
Breaking Biology Technology:
(Date:12/16/2016)... NEW YORK , Dec. 16, 2016 The global ... reach USD 12.14 billion by 2021 from USD 5.31 billion in ... ... market is mainly driven by technological advancements in medical devices, launch ... devices, rising preference for wireless connectivity among healthcare providers, and increasing ...
(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)... Dec. 15, 2016 Advancements in ... health wellness and wellbeing (HWW), and security ... three new passenger vehicles begin to feature ... recognition, heart beat monitoring, brain wave monitoring, ... monitoring, and pulse detection. These will be ...
Breaking Biology News(10 mins):